Skip to the page

Data / Public companies / SIC 3841: Surgical and medical instruments and apparatus / Profound Medical Corp.

Profound Medical Corp.: revenue, net income and total assets from its latest annual report

Updated March 5, 2026. Source: SEC Financial Statement Data Sets, filing 0001104659-26-024153.

Profound Medical Corp. reported revenue of $16.1 million, a net loss of $42.6 million and total assets of $77.5 million for the fiscal year ended December 31, 2025, in its annual report (10-K) filed with the SEC on March 5, 2026. It ranks 85th by revenue of 119 companies in SIC 3841, surgical and medical instruments and apparatus.

The request: Watch Profound Medical Corp. (CIK 1628808): each new SEC filing, with revenue and net income. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.

SEC central index key (CIK)
1628808
Industry
SIC 3841, Surgical and medical instruments and apparatus
Business address (city and state)
Mississauga, Canada
Incorporated in
California
Filer category
Non-accelerated filer
Fiscal year ends
December 31
Latest annual report
10-K filed March 5, 2026
Annual and quarterly reports in the data
1 annual, 4 quarterly

Financials for the fiscal year ended December 31, 2025

As filed, in US dollars. The prior year value is the comparison column in the same report.

ItemThis yearPrior yearChangeSource
Revenue$16,098,000$10,680,00050.7%sec.gov
Operating income$-41,254,000Not listedNot listedsec.gov
Net income$-42,570,000$-27,816,000-53%sec.gov
Total assets$77,475,000$70,234,00010.3%sec.gov
Total liabilities$11,041,000Not listedNot listedsec.gov
Stockholders' equity$66,434,000Not listedNot listedsec.gov
Cash and cash equivalents$59,723,000Not listedNot listedsec.gov

How it compares

Net margin (net income over revenue)
-264.4%
Revenue change on the prior year
50.7%
Revenue rank in SIC 3841
85th of 119
Revenue rank among all companies in the data
3,512th of 4,486

Companies next to it by revenue in SIC 3841

Surgical and medical instruments and apparatus, from the same data.

CompanyBusiness addressRevenueNet incomeTotal assetsRevenue change
Spectral Ai, Inc.Dallas, TX$19.7 million$-7,571,000$21.4 million-33.6%
Sonoma Pharmaceuticals, Inc.Boulder, CO$19.5 million$-3,175,000$14 million36.7%
Nephros IncSouth Orange, NJ$18.8 million$1.2 million$13.6 million32.7%
Vivos Therapeutics, Inc.Littleton, CO$17.4 million$-21,170,000$25.2 million16%
Biotricity Inc.Redwood City, CA$16 million$-2,404,139$6.4 million16%
Allurion Technologies, Inc.Natick, MA$15.2 million$-28,755,000$15.8 million-52.6%
Nexgel, Inc.Langhorne, PA$11.4 million$-3,000,000$10.5 million31.5%
Medinotec Inc.Johannesburg$9.7 million$794,502$6.8 million6.8%

Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.